NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Crosses Above 50 Day Moving Average – Here’s What Happened

Shares of NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.76. NovaBay Pharmaceuticals shares last traded at $0.72, with a volume of 920,588 shares changing hands.

NovaBay Pharmaceuticals Stock Down 5.3 %

The company has a market capitalization of $3.01 million, a PE ratio of -0.07 and a beta of 2.82.

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) last announced its earnings results on Tuesday, August 13th. The biopharmaceutical company reported ($1.37) EPS for the quarter. The business had revenue of $2.40 million during the quarter. NovaBay Pharmaceuticals had a negative return on equity of 146.20% and a negative net margin of 79.70%. As a group, equities research analysts expect that NovaBay Pharmaceuticals, Inc. will post -2.54 EPS for the current fiscal year.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.